Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

Clinical Trial ID NCT01800422

PubWeight™ 1.53‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01800422

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antiprogestins in gynecological diseases. Reproduction 2014 0.78
2 Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes. BMC Cancer 2016 0.75
Next 100